Martha Goldberg Aronson - 10 May 2021 Form 4 Insider Report for Cardiovascular Systems Inc

Role: Director
Signature: /s/ Amanda Lorentz as Attorney-in-Fact for Martha Goldberg Aronson pursuant to Power of Attorney previously filed.
Issuer symbol: N/A
Transactions as of: 10 May 2021
Net transactions value: +$51,885
Form type: 4
Filing time: 11 May 2021, 08:04:32 UTC
Next filing: 03 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSII	Common Stock	Purchase	$51,885	+1,500	+25%	$34.59	7,500	10 May 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CSII	Restricted Stock Units						12,277	10 May 2021	Common Stock	12,277		Direct	F1
holding	CSII	Restricted Stock Units						2,411	10 May 2021	Common Stock	2,411		Direct	F2
holding	CSII	Restricted Stock Units						4,661	10 May 2021	Common Stock	4,661		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
F2	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment, and shall be payable in cash or shares of Company common stock on the payment date.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,166 shares on September 30, 2020 and 1,165 shares on each of December 31, 2020, March 31, 2021 and June 30, 2021.